Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Sep 13;51(1):980.
doi: 10.1007/s11033-024-09919-2.

Exploration of SOD3 from gene to therapeutic prospects: a brief review

Affiliations
Review

Exploration of SOD3 from gene to therapeutic prospects: a brief review

Amin Kalmari et al. Mol Biol Rep. .

Abstract

Superoxide dismutase 3 (SOD3) is a type of antioxidant enzyme, which plays an important role in converting superoxide anion into hydrogen peroxide through its extracellular activity. This enzyme has been widely studied and evaluated from various points of view, including maintaining cellular redox balance, protecting against oxidative damage, and enhancing overall cellular resilience. The current paper focuses on SOD3 expression from a functional perspective. In addition to a detailed examination of the gene and protein structure, we found ample evidence indicating that the expression level of SOD3 undergoes alterations in response to various transcription factors, signaling pathways, and diverse conditions. These fluctuations, by disrupting the homeostasis of SOD3, can serve as crucial indicators of the onset or exacerbation of specific diseases. In this regard, significant efforts have been dedicated in recent years to the treatment of diseases through the regulation of SOD3 expression. The ultimate goal of this review is to extensively highlight and demonstrate the immense potential of SOD3 as a therapeutic target, emphasizing its profound impact on health outcomes.

Keywords: Antioxidant enzyme; Gene expression regulation; Protein structure; SOD3; Therapeutic target.

PubMed Disclaimer

Similar articles

References

    1. İnal ME, Kanbak G, Sunal E (2001) Antioxidant enzyme activities and malondialdehyde levels related to aging. Clin Chim Acta 305(1–2):75–80. https://doi.org/10.1016/S0009-8981(00)00422-8 - DOI - PubMed
    1. Wang Y, Branicky R, Noë A, Hekimi S (2018) Superoxide dismutases: dual roles in controlling ROS damage and regulating ROS signaling. J Cell Biol 217(6):1915–1928. https://doi.org/10.1083/jcb.201708007 - DOI - PubMed - PMC
    1. Islam MN et al (2022) Superoxide dismutase: an updated review on its health benefits and industrial applications. Crit Rev Food Sci Nutr 62(26):7282–7300. https://doi.org/10.1080/10408398.2021.1913400 - DOI - PubMed
    1. Eleutherio ECA, Magalhães RSS, de Araújo Brasil A, Neto JRM, de Holanda Paranhos L (2021) SOD1, more than just an antioxidant. Arch Biochem Biophys 697:108701. https://doi.org/10.1016/j.abb.2020.108701 - DOI - PubMed
    1. Lewandowski Ł, Kepinska M, Milnerowicz H (2020) Alterations in concentration/activity of superoxide dismutases in context of obesity and selected single nucleotide polymorphisms in genes: SOD1, SOD2, SOD3. Int J Mol Sci 21(14):5069. https://doi.org/10.3390/ijms21145069 - DOI - PubMed - PMC

LinkOut - more resources